{
    "2021-04-23": [
        [
            {
                "time": "",
                "original_text": "千亿元市值的药企迷恋“副业”？复星医药能否 “复兴”？",
                "features": {
                    "keywords": [
                        "千亿元",
                        "药企",
                        "复星医药",
                        "复兴"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "八大券商主题策略：寻找医药变革中的长牛品种 持续推荐“六个方向”",
                "features": {
                    "keywords": [
                        "券商",
                        "医药",
                        "长牛品种",
                        "六个方向"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "解盘：茅股一枝独秀，疫苗、锂矿、特高压等板块涨幅居前",
                "features": {
                    "keywords": [
                        "茅股",
                        "疫苗",
                        "锂矿",
                        "特高压",
                        "涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "新能源",
                        "电力设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】复星医药(02196-HK)涨3.15%",
                "features": {
                    "keywords": [
                        "异动股",
                        "复星医药",
                        "涨3.15%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "辉瑞mRNA疫苗针对中国人群的1期临床试验发表",
                "features": {
                    "keywords": [
                        "辉瑞",
                        "mRNA疫苗",
                        "中国人群",
                        "1期临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}